New Delhi, May 06, 2024 (GLOBE NEWSWIRE) -- Astute Analytica states that the global apheresis market was valued at US$ 3,248.3 million in 2023 and is estimated to surpass market valuation of US$ 6,882 ...

- In the changed post COVID-19 business landscape, the global market for Apheresis Equipment estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$3.6 Billion by ...

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial The study included CAR T-cell ...

Previous studies have suggested that leukocyte apheresis, which selectively removes about 65% of activated granulocytes and 55% of activated monocytes from peripheral blood, can improve IBD symptoms ...

Familial hypercholesterolemia is an autosomal dominant disorder resulting in severe elevation of total and LDL cholesterol due to defective hepatic LDL receptor. Heterozygotes occur in about 1 of 500 ...

The fifth annual Apheresis Awareness Day is recognized on Tuesday, September 17, 2024, as designated by the American Society for Apheresis (ASFA). The purpose is to raise awareness of apheresis ...

span class="inline inline-left">PHOTO: COURTESY OF SILOAM HOSPITALS LIPPO VILLAGE“Patients suffering from autoimmune diseases no longer need weeks or months of ...

“The Transfusion Medicine Service in the Department of Pathology performs therapeutic apheresis on patients who have an illness associated with an abnormal cellular or plasma-based blood component,” ...

Jeffrey Frist was getting desperate. Diagnosed with familial hypercholesterolemia (FH) in 2012 after his first heart attack the year before, he had experienced a cardiovascular event every 11 months ...

During the projection period, it is predicted that demand for therapeutic apheresis would increase at a CAGR of 6.8%. The Therapeutic Apheresis Market share is anticipated to be worth US$ 2577.9 ...